A Collaboration Between the EAU-ESPU Pediatric Urology Guidelines and the IFSBH

December 9, 2024 updated by: Lisette 't Hoen, Erasmus Medical Center

Assessing Patient Centered Urological Care for Spina Bifida: a Collaboration Between the EAU-ESPU Pediatric Urology Guidelines Panel and the IFSBH.

Children with spina bifida require care from various medical and paramedical specialists throughout their life. The availability and organization of the care needed differs between the European countries. The EAU and IFSBH are both organizations with the aim to improve patient care and clinical outcomes for children with spina bifida.

The investigators have set up a collaboration to evaluate the differences in organization of care and clinical treatment received and how this affects outcomes with regard to quality of life and sexuality.

A digital survey has been constructed which will be distributed among children and adolescents with spina bifida and their caregivers. The IFSBH and national patient organizations will send out invitations to their members. Children and adolescents from 8 - 18 years of age with spina bifida are eligible for inclusion.

The survey includes a primary survey developed in collaboration between panel members of the EAU pediatric urology guidelines and patient representatives. The second part includes validated questionnaires to evaluate Quality of life with the QUALAS and sexual function with the IIEF-5/FSFI-6 for boys/girls respectively.

Primary outcome will be the quality of life in children and adolescents with spina bifida. The team will evaluate if their demographic differences influence the quality of life and if differences are seen between the different European countries. Secondary outcomes include differences in sexual function, organization of care, treatment received, treatment options available, with also a focus on differences between the different European countries.

The results of this survey will be evaluated and interpreted within a sounding board group consisting of children/adolescents/adults with spina bifida, patient representatives from IFSBH and panel members of the EAU Pediatric Urology guidelines panel. Finally, the interpreted results will be used to update the EAU Pediatric Urology guidelines to make these more patient centered.

There are no known risks of participating in the study given the fact that participation includes only completion of questionnaires and data about standard of care. Furthermore, the study is completely voluntary and the results will be completely anonymous.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction and rationale Children with spina bifida require care from various medical and paramedical specialists throughout their life. The availability and organization of the care needed differs between the European countries. It can be expected that this variety results in differences in outcome of care.

Children with spina bifida have stated that for future research they feel it is important that quality of life and sexuality are investigated.

The EAU Pediatric Urology guidelines panel wants to ensure that patients with spina bifida receive the best possible care based on the best available clinical evidence. Additionally, this team wants to improve the clinical guidelines by including patients perspectives. The IFSBH represents patients with spina bifida and values the promotion and protection of the human rights of patients with spina bifida thereby improving quality of life.

Together with the IFSBH the investigators have set up a collaboration to investigate how the team can make the guidelines more patient centered and thereby improve quality of care and quality of life.

For this aim the investigators have developed a survey to evaluate the current organization of care, demographic features and received treatment. The outcome of this survey will show the exact differences in care between European countries. The investigators have included two validated questionnaires to measure the effect this has on quality of life and sexuality. The information gathered will be used to adapt the clinical EAU Pediatric Urology guidelines.

Objective(s) The main objective is to improve the quality of life of patients with spina bifida by updating the guidelines according to the differences found in care and how this impacts patients outcomes.

The team will evaluate the difference in organization of care between different European countries based on the outcomes of the primary survey. The baseline quality of life and sexuality reported will be evaluated with the QUALAS and the IIEF-5/FSFI-6 questionnaires. The investigators will then explore the relationship between how care is organized and how this affects quality of life and sexuality. The results of this study will be used to update the EAU Pediatric Urology clinical guidelines. Also, it will highlight the direction for future research to improve patients care and thereby quality of life and/or sexuality, which patients with spina bifida have stated they themselves find important.

Methods This digital survey includes a primary survey regarding basic demographic features, medical treatment and organization of care. This survey was constructed by the EAU guidelines panel and the IFSBH patient representatives. The second part of the digital survey includes two validated questionnaires. The QUALAS is a validated questionnaire regarding quality of life in patients with spina bifida. There are two different versions for the ages 8-12 and 13-18 years. To evaluate sexuality the IIEF-5 (for boys) and the FSFI-6 (for girls) are used. These questionnaires are validated and are used in patients with spina bifida to evaluate sexual function as standard of care. Only children aged 13 years or older will be asked if they want to answer questions about sexuality and if they answer yes they will be asked for which gender they want to answer questions about their sexuality. After this they'll get the IIEF-5 or FSFI-6 questionnaire.

This digital survey is available in nine languages: English, Spanish, German, Italian, French, Danish, Greek, Turkish and Dutch.

The link to surveymonkey will be distributed by the IFSBH and local patient organizations among their members.

After the data have been collected, the general results of the survey will be evaluated and interpreted with a sounding board group. When patients participate with the digital survey they will not be involved in the sounding group. This sounding board group will consist of children/adolescents/adults with spina bifida who are representatives from the patient organization IFSBH and panel members of the EAU. This sounding board group will meet for a day. Finally, the results will be used to update the EAU Pediatric Urology guidelines.

Study Type

Observational

Enrollment (Actual)

281

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rotterdam, Netherlands, 3015GD
        • Erasmus MC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

People with spina bifida who are approached by their representative organizations

Description

Inclusion Criteria:

  • Must have spina bifida
  • Must be able to complete the digital survey, with help of caregivers allowed.
  • Speak one of the nine available languages:

    • English,
    • Spanish,
    • German,
    • Italian,
    • French,
    • Danish,
    • Greek,
    • Turkish,
    • Dutch

Exclusion Criteria:

  • Does not have spina bifida

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
People with spina bifida
People with spina bifida are approached through representative organizations by email to complete a digital survey at 1 timepoint.
Survey containing a primary survey regarding basic demographic features, medical treatment and organization of care and two validated questionnaires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QUALAS score
Time Frame: 6 months
Score derived from the Quality of Life Assessment in Spina Bifida (QUALAS) survey Scores range from 0-100 with higher scores indicating better quality of life
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic parameters
Time Frame: 6 months
Gender, age, medication use, catheter use, organization of care
6 months
IIEF score
Time Frame: 6 months
Score derived from the International Index of Erectile Function (IIEF) survey Scores range from 1-25 with higher scores indicating better erectile function
6 months
FSFI score
Time Frame: 6 months
Score derived from the Female Sexual Function Index (FSFI) survey. Scores range from 2-30 with higher scores indicating better sexual function
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisette 't Hoen, MD, PhD, Erasmus Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2023

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

December 4, 2024

First Submitted That Met QC Criteria

December 9, 2024

First Posted (Estimated)

December 10, 2024

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 9, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe